Breaking the Ice: Advancing Psoriasis Preclinical Models in Winter’s Grip
Accelerate Your Psoriasis Drug Discovery with MLM’s IL-23-Induced and IMQ-Induced Preclinical Disease Models by Katie Dineen, BS, Business Development Manager for Pre-Clinical Research As winter sweeps across the United States with record-breaking cold temperatures, researchers studying psoriasis and related skin diseases are uniquely positioned to address the heightened challenges these conditions present. The dry, frigid […]
Breaking the Ice: Advancing Psoriasis Preclinical Models in Winter’s Grip Read More »